POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29 | +38.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $21 | -43.2% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $37 | -42.2% | 12,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $64 | -99.8% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $42,000 | +35.5% | 12,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $31,000 | -42.6% | 12,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $54,000 | -34.1% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $82,000 | -5.7% | 12,000 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $87,000 | -27.5% | 12,000 | 0.0% | 0.01% | -30.0% |
| Q2 2021 | $120,000 | +4.3% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $115,000 | -12.9% | 12,000 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $132,000 | -17.5% | 12,000 | -33.3% | 0.01% | -23.5% |
| Q3 2020 | $160,000 | – | 18,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |